Advertisement.

QNRX Projected Dividend Yield

Sponsored ADR (New)/Quoin Pharmaceuticals Ltd ( NASDAQ : QNRX )

Quoin Pharmaceuticals is a biotechnology company that has developed a platform known as ApoGraft that functionally selects stem cells in order to improve the regenerative medicine and stem cell therapies. Co. is conducting two clinical trials of ApoGraft, a Phase I/II clinical trial in Israel and a Phase I clinical study in Washington University. In addition, Co. is in the process of scaling up its product manufacturing capabilities based on its ApoGraft technology. ApoGraft is being tested for clinical use in allogeneic matched and half matched donors Hematopoietic Stem Cells Transplantation for the treatment of hematological malignancies (blood cancers such as leukemia and lymphoma).

20 YEAR PERFORMANCE RESULTS

QNRX Dividend History Detail
QNRX Dividend News
QNRX Competitors News

# of Shares: 0

Closing Price: 0.66

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000